Anlotinib Plus S-1 for Patients with EGFR Mutation-Negative Advanced Squamous Cell Lung Cancer with PS Scores of 2–3 After Progression of Second-Line or Later-Line Treatment

by Xie XH, Wang F, Lin XQ, Qin YY, Xie ZH, Zhang JX, Ouyang M, Zhou CZ
Published 2020-12-01

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis

by Lv WF, Liu KC, Lu D, Zhou CZ, Cheng DL, Xiao JK, Zhang XM, Zhang ZF
Published 2018-10-01

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma

by Liu KC, Hao YH, Lv WF, Jia WD, Ji CS, Zhou CZ, Cheng DL, Xu SB, Gao ZG, Su MX, Shi CS
Published 2020-08-01